Henry Schein (NASDAQ:HSIC) Share Price Passes Above 200 Day Moving Average – Time to Sell?

Shares of Henry Schein, Inc. (NASDAQ:HSIC) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $76.87 and traded as high as $84.42. Henry Schein shares last traded at $83.52, with a volume of 1,250,689 shares trading hands.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. Robert W. Baird set a $97.00 target price on shares of Henry Schein in a report on Wednesday, May 6th. Citigroup assumed coverage on shares of Henry Schein in a report on Wednesday, April 15th. They set a “buy” rating and a $100.00 price target on the stock. Wall Street Zen downgraded shares of Henry Schein from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 26th. BTIG Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Thursday, June 11th. Finally, Morgan Stanley reaffirmed an “underweight” rating and issued a $64.00 price objective (up from $61.00) on shares of Henry Schein in a research report on Friday, April 24th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $87.85.

Henry Schein Price Performance

The firm has a fifty day moving average of $76.77 and a 200 day moving average of $76.87. The company has a market capitalization of $9.51 billion, a P/E ratio of 25.23, a P/E/G ratio of 1.62 and a beta of 0.82. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.20 by $0.12. The business had revenue of $3.37 billion for the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post 5.32 EPS for the current year.

Insider Buying and Selling at Henry Schein

In related news, Director William K. Daniel acquired 10,000 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was purchased at an average cost of $69.19 per share, with a total value of $691,900.00. Following the completion of the acquisition, the director directly owned 20,000 shares of the company’s stock, valued at approximately $1,383,800. This trade represents a 100.00% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.89% of the stock is owned by insiders.

Institutional Investors Weigh In On Henry Schein

A number of large investors have recently added to or reduced their stakes in HSIC. Assenagon Asset Management S.A. increased its stake in shares of Henry Schein by 212.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 67,181 shares of the company’s stock worth $5,078,000 after purchasing an additional 45,701 shares in the last quarter. Kettle Hill Capital Management LLC purchased a new position in Henry Schein during the third quarter valued at $14,158,000. Tudor Investment Corp ET AL bought a new stake in Henry Schein during the third quarter valued at about $15,375,000. Snyder Capital Management L P increased its position in Henry Schein by 18.6% in the third quarter. Snyder Capital Management L P now owns 1,334,364 shares of the company’s stock worth $88,562,000 after buying an additional 209,123 shares in the last quarter. Finally, SG Americas Securities LLC increased its position in Henry Schein by 171.9% in the fourth quarter. SG Americas Securities LLC now owns 820,698 shares of the company’s stock worth $62,028,000 after buying an additional 518,914 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.